Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Arvind Kejriwal says AAP government served Delhi honestly for 10 years He promises to waive 'inflated' water bills if AAP is voted to power BJP's Virendra Sachdeva accuses Arvind Kejriwal of ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price target of $145.00. The company’s shares closed last ...

According to the list, AAP's national convener Arvind Kejriwal, former Deputy CM of Delhi Manish Sisodia, Punjab CM Bhagwant Mann, Delhi CM Atishi, and Rajya Sabha MP Sanjay Singh will campaign ...

Image Source : PTI (FILE) Aam Aadmi Party Convenor Arvind Kejriwal. Maharashtra Assembly Election 2024: The Aam Aadmi Party (AAP) Convenor Arvind Kejriwal will campaign for I.N.D.I.A bloc ...

AAP leaders on Friday claimed Kejriwal was attacked by "BJP goons" during his 'padyatra' campaign in west Delhi's Vikaspuri.

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...

The movie is set in 1996. Arunmozhi Varman (Arvind Swami) was forced to leave his family house in Thanjavur along with his parents owing to a few problems. After 20 years, Arun returns to Guntur ...

Meiyazhagan, starring Karthi and Arvind Swamy in the lead roles, is still running in theatres, but it’s currently in the final leg of its theatrical run. Considering the face value and reception ...

In line with the preparations for the Delhi Assembly polls, Aam Aadmi Party Chief Arvind Kejriwal will hold a meeting with the leaders of the party today. The meeting will be held in Pitampura area of ...

Speaking to PTI Videos upon his release, he stated, “I will do whatever our party and Arvind Kejriwal say,” emphasizing his commitment to the AAP’s direction. This 83-year-old billionaire is ...

In 2021, with the COVID-19 pandemic in full swing, BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were the darlings of the pharma and biotech worlds. The two mRNA therapy developers created ...